Home › Trial NCT07369895
Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
- Trial IDNCT07369895
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorO&D BioTech Group CO., Limited
- Enrollment18
- Start date2025-10-28
- ConditionsRelapsed or Refractory Multiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.